NobleStitch Patent Foramen Ovales Closure for Recurrent Strokes in a Patient with COVID-19 on Extracorporeal Membrane Oxygenation
SEVERE HYPOXEMIA, secondary to the SARS-COV-2 (COVID-19) pneumonia, is a significant contributor to morbidity and mortality.1 Patent foramen ovales (PFOs) can exacerbate hypoxemia through an intracardiac shunt, slowing recovery and worsening outcomes.2-4 Cryptogenic stroke is a complication commonly associated with PFOs; however, current guidelines do not address PFO management in COVID-19 patients who experience recurrent paradoxical emboli, especially in the setting of COVID-19 pneumonia, increased right-sided pressures, and a hypercoagulable state.
Source: Journal of Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Authors: Perry A. Stout, Nika Samadzadeh Tabrizi, Matt Tribble, Tanya Richvalsky, Cindy Youn, Brion Winston MD, Alexander D. Shapeton, Sridhar R. Musuku Tags: Case Report Source Type: research
More News: Anesthesia | Anesthesiology | Cardiology | COVID-19 | Heart | Patent Foramen Ovale | Pneumonia | SARS | Stroke